Important Information: Combined hormonal contraceptives: Europe-wide review confirms the risk of thromboembolism is small and agrees updated information to reflect the latest evidence.
Please see the MHRA Central Alerting System (CAS) website for more information and information to download for patients and healthcare professionals:
Click Here for MHRA CAS Alert Website
For further sales information please contact customer services on 01509 217705 or email This email address is being protected from spambots. You need JavaScript enabled to view it.
For medical enquiries please contact medical information on +44 (0) 116 478 0322.